Podcast: Data beyond a study’s main objective provide strategic insights
In this episode, Craig Chambliss, CEO of Neurelis, outlines what analytic strategies can enhance the value of clinical data.
Themes
Australia starts investigation into OpenAI Medicare breach
Saturated fat increases the risk of mortality in non-metastatic prostate cancer
Study finds metabolic biomarker signature to assist with early HNSCC detection
Industry partnership will determine the success of the transition to low-GWP pMDIs
TrialAssure selected as EMA’s official clinical trial anonymisation partner
ASCO26: AI innovations show promise in reducing the oncology RWD burden
Keeping pace with generative AI in pharmaceutical and healthcare organisations
